All Curated Mutation Sites in CHIKV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in CHIKV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
6K
  
C
  
E1
  
E2
  
E3
  
nsP1
  
nsP2
  
nsP3
  
nsP4
  
Pol
  

Keyword: Chikungunya Fever-27430542
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 27430542 V371L
E2
E2
Chikungunya Fever
G
S
View
2 27430542 K211E
E1
E1
Chikungunya Fever
G
S
L
View
3 27430542 A98T
E1
E1
Chikungunya Fever
G
S
View
4 27430542 L20M
6K
Chikungunya Fever
G
S
View
5 27430542 V368A
E2
E2
Chikungunya Fever
G
S
View
6 27430542 L248F
E2
E2
Chikungunya Fever
G
S
View
7 27430542 A47T
6K
Chikungunya Fever
G
S
View
8 27430542 A56V
6K
Chikungunya Fever
G
S
View
9 27430542 H351R
E2
E2
Chikungunya Fever
G
S
View
10 27430542 A47S
6K
Chikungunya Fever
G
S
View
11 27430542 F48L
6K
Chikungunya Fever
G
S
View
12 27430542 L133F
E1
E1
Chikungunya Fever
G
S
View
13 27430542 A226V
E1
E1
Chikungunya Fever
G
S
View
14 27430542 K252Q
E2
E2
Chikungunya Fever
G
S
View
15 27430542 K233E
E2
E2
Chikungunya Fever
G
S
View
16 27430542 K233Q
E2
E2
Chikungunya Fever
G
S
View
17 27430542 V222I
E2
E2
Chikungunya Fever
G
S
View
18 27430542 K211N
E1
E1
Chikungunya Fever
G
S
View
19 27430542 R198Q
E2
E2
Chikungunya Fever
G
S
View
20 27430542 L210Q
E2
E2
Chikungunya Fever
G
S
View
21 27430542 L248Q
E2
E2
Chikungunya Fever
G
S
View
22 27430542 K234E
E2
E2
Chikungunya Fever
G
S
View
Contents
Description

The table shows all curated mutation sites of CHIKV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.